- Angelia J., Weng X., Solomatov A., Chin C.UG (Psychology '22), Fernandez A.PB (PHAP '22), Hudson P.K., Morisseau C., Hammock B.D., Kandasamy R.C, Pecic SC. (2023). Structure-activity relationship studies of benzothiazole-phenyl analogs as multi-target ligands to alleviate pain without affecting normal behavior. Prostaglandins and Other Lipid Mediators, in press. PMID: 36529320
- Wilt S., Kodani S., Valencia L., Hudson P.K., Sanchez S.UG (Biological Sciences '23), Quintana T.UG (Psychology, Biological Sciences '22), Morisseau C., Hammock B.D., Kandasamy R.C, Pecic SC. (2021). Further exploration of the structure-activity relationship of dual soluble epoxide hydrolase/fatty acid amide hydrolase inhibitors. Bioorganic & Medicinal Chemistry, 51, 116507. PMID: 34794001
- Rodriguez C.E.B.F,UG (Psychology '20), Ouyang L.F,UG (Biological Sciences '23), Kandasamy R.C (2021). Antinociceptive effects of minor cannabinoids, terpenes, and flavonoids in Cannabis. Behavioural Pharmacology, in press. PMID: 33709984
- Kandasamy R.F, Hillhouse T.M.F, Livingston K.E., Kochan K.E., Meurice C., Eans. S.O., Li M., White A.D., Roques B.P., McLaughlin J.P., Ingram S.L., Burford N.T., Alt A., Traynor J.R. (2021). Positive allosteric modulation of the mu-opioid receptor produces analgesia with reduced side-effects. Proceedings of the National Academy of Sciences, 118(16), e2000017118. PMID: 33846420
- Kandasamy R.C and Morgan M.M. (2021). “Reinventing the wheel” to advance the development of pain therapeutics. Behavioural Pharmacology, 32(2&3), 142-152. PMID: 33079736
- Senese N.B., Kandasamy R., Kochan K.E., Traynor J.R. (2020). Regulator of G-Protein Signaling (RGS) Protein Modulation of Opioid Receptor Signaling as a Potential Target for Pain Management. Frontiers in Molecular Neuroscience, 13:5. PMID: 32028168
- Stanczyk M.A. and Kandasamy R. (2018). Biased agonism: The quest for the analgesic holy grail. PAIN Reports, 3(3), e650. PMID: 29922742
- Kandasamy R., Dawson C.T.UG, Hilgendorf T.N.UG, Morgan M.M. (2018). Medication overuse headache following repeated morphine, but not ∆9-tetrahydrocannabinol administration in the female rat. Behavioural Pharmacology, 29(5), 469-472. PMID: 29462111
- Kandasamy R., Dawson C.T.UG, Craft, R.M., Morgan M.M. (2018). Anti-migraine effect of ∆9-tetrahydrocannabinol in the female rat. European Journal of Pharmacology, 818, 271-277. PMID: 29111112
- Kandasamy R., Lee A.T.UG, Morgan M.M. (2017). Depression of home cage wheel running is an objective measure of spontaneous morphine withdrawal in rats with and without persistent pain. Pharmacology, Biochemistry and Behavior, 156, 10-15. PMID: 28366799
- Kandasamy R., Lee A.T.UG, Morgan M.M. (2017). Depression of home cage wheel running: a reliable and clinically relevant method to assess migraine pain in rats. The Journal of Headache and Pain, 18(1):5, 1-8. PMID: 28091820
- Kandasamy R., Calsbeek J.J.UG, Morgan M.M. (2017). Analysis of inflammation-induced depression of home cage wheel running in rats reveals the difference between opioid antinociception and restoration of function. Behavioural Brain Research, 317, 502-507. PMID: 27746208
- Kandasamy R., Calsbeek J.J.UG, Morgan M.M. (2016). Home cage wheel running is an objective and clinically relevant method to assess inflammatory pain in male and female rats. Journal of Neuroscience Methods, 263, 115-122.PMID: 26891874
- Kandasamy R. and Price T.J. (2015). The pharmacology of nociceptor priming. In Pain Control (Handbook of Experimental Pharmacology) 15-37. Ed. H-G Schaible, Springer Berlin Heidelberg. PMID: 25846612
- Craft R.M., Kandasamy R., Davis S.M. (2013). Sex differences in anti-allodynic, anti-hyperalgesic and anti-edema effects of Δ9-tetrahydrocannabinol in the rat. PAIN, 154(9), 1709-1717. PMID: 23707295
UG = undergraduate co-author
PB = postbaccalaureate co-author
F = co-first author
C = corresponding author